V35-26887-53331
4 vaccinations
2 coded responses
53 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 752 / TX
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
2BZ-10068-04451
Child or adolescent in my care · Male · 2021-11-09
Q69-16745-69743
Child or adolescent in my care · Female · 2022-06-24
2BU-89423-79248
Child or adolescent in my care · Male · 2022-06-24
Timeline
-
2020-12-19
Registered in v-safe
-
2020-12-19
Dose 1 — Pfizer-BioNTech
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2021-01-02
-
2021-01-09
Dose 2 — Pfizer-BioNTech
- 2021-01-09
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-10
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-23
- 2021-01-30
- 2021-02-06
-
2021-02-06
Call successfulDoes not wish to fill out VAERS report
- 2021-02-13
- 2021-02-20
- 2021-04-10
- 2021-07-12
-
2021-11-09
Dose 3 — Pfizer-BioNTech
- 2021-11-09
- 2021-11-11
- 2021-11-12
- 2021-11-13
- 2021-11-14
- 2021-11-15
- 2021-11-16
-
2021-11-23
Survey response — day 14, dose 3MedDRA: Nausea — Feeling: Good · Be unable to do your normal daily activitiesFree text: NauseaMedDRA releases: 2024-11 · check-in free text available
- 2021-11-30
- 2021-12-07
- 2021-12-14
- 2021-12-21
- 2022-02-08
- 2022-05-10
-
2022-10-18
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-18
- 2022-10-19
- 2022-10-20
- 2022-10-21
- 2022-10-22
- 2022-10-23
- 2022-10-24
- 2022-10-25
- 2022-11-01
- 2022-11-08
- 2022-11-15
-
2022-11-22
Survey response — day 35, dose 4MedDRA: Bronchitis, Sinusitis — Feeling: Fair · Be unable to work or attend schoolFree text: Bronchitis and sinusitisMedDRA releases: 2024-11 · check-in free text available
- 2022-11-29
- 2023-01-17
- 2023-04-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-11-09 | Pfizer-BioNTech | No |
| 4 | 2022-10-18 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-10 | Successful 2021-02-06 |
Does not wish to fill out VAERS report |
Free text
Release 10 — day 14, dose 3
Symptoms: Nausea
Release 12 — day 35, dose 4
Symptoms: Bronchitis and sinusitis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchitis | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release